Ozanimod induction therapy for patients with moderate to severe Crohn's disease: a single-arm, phase 2, prospective observer-blinded endpoint study

Ozanimod induction therapy for patients with moderate to severe Crohn's disease: a single-arm, phase 2, prospective observer-blinded endpoint study / Feagan, Brian G; Sandborn, William J; Danese, Silvio; Wolf, Douglas C; Liu, Wenzhong J; Hua, Steven Y; Minton, Neil; Olson, Allan; D'Haens, Geert. - In: THE LANCET. GASTROENTEROLOGY & HEPATOLOGY. - ISSN 2468-1253. - 5:9(2020), pp. 819-828. [10.1016/S2468-1253(20)30188-6]